FacebookTwitterRedditEmail

FDA Commissioner Hamburg Appointed WHO Deputy?

Many had high hopes for the FDA when Margaret Hamburg was confirmed as Commissioner in 2009 because of her public health background. But she swiftly moved to loosen conflict of interest rules governing those who can serve on FDA expert advisory panels, claiming it was too hard to find experts without Pharma financial links.

Her move followed a Philadelphia Inquirer reporter’s revelations that child psychiatrist Jorge Armenteros, a paid consultant to AstraZeneca, was on an FDA committee voting on–any guesses?–the AstraZeneca drug Seroquel.

Last month, more questions about embedded conflicts of interest at the FDA were raised when Commissioner Hamburg appointed Robert Califf, M.D., chancellor of clinical and translational research at Duke University, as the next FDA Deputy Commissioner for Medical Products and Tobacco despite a thicket of conflicts of interest. It was one of her last official acts before announcing her resignation last week.

A disclosure statement on the website of Duke Clinical Research Institute says “Robert M. Califf, MD, reports receiving research grant support from Novartis Pharmaceuticals, Johnson & Johnson/Scios, Lilly, Merck, and Schering Plough, and consulting fees from Annenberg, Aterovax, Bayer/Ortho McNeil, BMS, Boehringer Ingelheim, GSK, WebMd/theheart.org, Johnson and ohnson/Scios, Kowa Research Institute, McKinsey & Company, Medtronic, Merck, Novartis Pharmaceuticals, Sanofi Aventis, and Schering Plough, and has an equity position with NITROX, LLC.”

In disclosure information for a 2013 article in Circulation, Dr. Califf’s also lists financial links to Gambro, Regeneron, Gilead, AstraZeneca, Roche, others companies and equity positions in four medical companies. The medical website Medscape discloses that Dr. Califf “served as a director, officer, partner, employee, advisor, consultant or trustee for Genentech” as well as for Medscape LLC/theheart.org. Portola Pharmaceuticals says Dr. Califf served on the Board of Directors until he was appointed FDA Deputy Commissioner for Medical Products and Tobacco.

Appearing on PBS with Susan Dentzer after Vioxx was withdrawn because of its links to thousands of heart attacks and stroke, Dr. Califf said, “Merck played by the rules from everything that I’ve seen.” He also said, “many of us consult with the pharmaceutical industry, which I think is a very good thing. They need ideas and then the decision about what they do is really up to the person who is funding the study.” What?

This is not the first time Dr. Califf’s extreme Pharma links have not blocked him from consideration for a top government post. He was up for Dr. Hamburg’s job itself, reported Reutersalong with three others. At the time, some medical voices asked how someone who helps drug companies market their products could possibly be considered as the nation’s chief watchdog over unsafe medications.

Industry conflicts at the FDA cost lives. Recently Senators Joe Manchin (D-W.Va.) and David Vitter (R-La.) questioned whether the FDA’s approval last year of the synthetic opioid Zohydro stemmed from pay-to-play meetings with Big Pharma who allegedly shelled out thousands to meet with regulators. Big Pharma’s hand in the opioid epidemic which causes 17,000 overdose deaths a year in the U.S. is well documented and egregious.

Commissioner Hamburg’s appointment of Dr. Califf amounts to a sad legacy. It also suggests the FDA is no longer even making a pretense at policing industry/government conflicts of interest.

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

bernie-the-sandernistas-cover-344x550
Weekend Edition
August 16, 2019
Friday - Sunday
Paul Street
Uncle Sam was Born Lethal
Jennifer Matsui
La Danse Mossad: Robert Maxwell and Jeffrey Epstein
Rob Urie
Neoliberalism and Environmental Calamity
Stuart A. Newman
The Biotech-Industrial Complex Gets Ready to Define What is Human
Nick Alexandrov
Prevention Through Deterrence: The Strategy Shared by the El Paso Shooter and the U.S. Border Patrol
Jeffrey St. Clair
The First Dambuster: a Coyote Tale
Eric Draitser
“Bernie is Trump” (and other Corporate Media Bullsh*t)
Nick Pemberton
Is White Supremacism a Mental Illness?
Jim Kavanagh
Dead Man’s Hand: The Impeachment Gambit
Andrew Levine
Have They No Decency?
David Yearsley
Kind of Blue at 60
Ramzy Baroud
Manifestos of Hate: What White Terrorists Have in Common
Evaggelos Vallianatos
The War on Nature
Martha Rosenberg
Catch and Hang Live Chickens for Slaughter: $11 an Hour Possible!
Neve Gordon
It’s No Wonder the Military likes Violent Video Games, They Can Help Train Civilians to Become Warriors
Yoav Litvin
Israel Fears a Visit by Ilhan Omar and Rashida Tlaib
Susan Miller
That Debacle at the Border is Genocide
Ralph Nader
With the Boeing 737 MAX Grounded, Top Boeing Bosses Must Testify Before Congress Now
Victor Grossman
Warnings, Ancient and Modern
Meena Miriam Yust - Arshad Khan
The Microplastic Threat
Kavitha Muralidharan
‘Today We Seek Those Fish in Discovery Channel’
Louis Proyect
The Vanity Cinema of Quentin Tarantino
Bob Scofield
Tit For Tat: Baltimore Takes Another Hit, This Time From Uruguay
Nozomi Hayase
The Prosecution of Julian Assange Affects Us All
Ron Jacobs
People’s Music for the Soul
John Feffer
Is America Crazy?
Jonathan Power
Russia and China are Growing Closer Again
John W. Whitehead
Who Inflicts the Most Gun Violence in America? The U.S. Government and Its Police Forces
Justin Vest
ICE: You’re Not Welcome in the South
Jill Richardson
Race is a Social Construct, But It Still Matters
Dean Baker
The NYT Gets the Story on Automation and Inequality Completely Wrong
Nino Pagliccia
Venezuela Retains Political Control After New US Coercive Measures
Gary Leupp
MSNBC and the Next Election: Racism is the Issue (and Don’t Talk about Socialism)
R. G. Davis
Paul Krassner: Investigative Satirist
Negin Owliaei
Red State Rip Off: Cutting Worker Pay by $1.5 Billion
Christopher Brauchli
The Side of Trump We Rarely See
Curtis Johnson
The Unbroken Line: From Slavery to the El Paso Shooting
Jesse Jackson
End Endless War and Bring Peace to Korea
Adolf Alzuphar
Diary: What About a New City Center?
Tracey L. Rogers
Candidates Need a Moral Vision
Nicky Reid
I Was a Red Flag Kid
John Kendall Hawkins
The Sixties Victory Lap in an Empty Arena
Stephen Cooper
Tony Chin’s Unstoppable, Historic Career in Music
Charles R. Larson
Review: Bruno Latour’s Down to Earth: Politics in the New Climatic Regime
Elizabeth Keyes
Haiku Fighting
FacebookTwitterRedditEmail